Innovations
Drugs
Vitiligo Treatment: Lynk Pharma Begins Phase II Clinical Trial of LNK01004 Ointment
Beyond vitiligo, Lynk Pharmaceuticals is also advancing the clinical development of LNK01004 for other inflammatory skin conditions, including chronic hand eczema.

